Fenix,
you mentioned that you were a physician. Does the data on eGFR (big jump up in Phase 2), Alkaline Phosphatase (big falls), LDL & HDL not impact your analysis?
These are the data points that I hang my hat on, despite the fact that the trials are based on post hoc analysis. Along with the 9 data safety review boards.